I guess all the 'unmet needs' talk and the 'low survival rates' are just nonsense then regardless of what organisation it is coming from ?
Who to believe I guess ... an anonymous poster on a stock forum or organisations like the FDA, BMT and NIH ? It's a tough call but I will go with places like BMT, NIH etc
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585098/
Published online 2023 Oct 5
Novel therapies for graft versus host disease with a focus on cell therapies
Thus, there is still an unmet need in terms of greater efficacy and increased long-term survival for SR-aGVHD patients.
https://www.targetedonc.com/view/navigating-unmet-needs-in-sr-d-cgvhd
February 7, 2024
Navigating Unmet Needs in SR/D cGvHD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192843/
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
I guess all the 'unmet needs' talk and the 'low survival rates'...
-
- There are more pages in this discussion • 864 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |